SCHEMBL5147360

SCHEMBL5147360

CC1(C)NC(=O)N(CCNc2ncc(Br)c(-c3cc4cnccc4s3)n2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.35
ALDH1A1 P00352 6/20 0.35
TGFBR1 P36897 9/20 0.34
MAPK14 Q16539 6/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
CDK2 P24941 1/20 0.33
CLK1 P49759 1/20 0.33
HTT P42858 1/20 0.33
MAPT P10636 1/20 0.33
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
TGFB2 P61812 1/20 0.31
PLA2G7 Q13093 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5145889 0.93 ALDH1A1 (0.35) CYP2A6ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5147380 0.90 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL5147313 0.87 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL5148362 0.87 CDK2 (0.39) CYP2A6TGFBR1MAPK14CDK2CLK1
SCHEMBL5148335 0.86 PDE3B (0.36) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL2986566 0.85 CYP2A6 (0.34) CYP2A6TGFBR1MAPK14HDAC3HDAC1
SCHEMBL5147302 0.85 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL5147498 0.85 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL5149101 0.83 RAF1 (0.37) TGFBR1MAPK14
SCHEMBL5147318 0.83 GAA (0.40) ALDH1A1SMN1; SMN2NPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed